Increasing Resistance According to Patient's Age and Sex in Escherichia coli Isolated from Urine in Italy

References

• Privitera G, Visona G, Porretta A, Panceri L, Marchetti F. Epidemiologia e modalita di gestione delle infezioni batteri-che nei servizi di Pronto Soccorso italiani. 39° Congress ofthe Italian Society of Hygiene, September 24-27, 2000, Ferrara, Italy.
   Google Scholar
• Bosisio V, Stella R, Castagna S, Marchetti F. A prospec-tive, descriptive study on the practise of management of uri-nary tract infections by general pratictioners in Italy: epidemi-ology (Part I). 2003. Archivio Italiano di Urologia e Andrologia 2003; 75 (2): 88-92.
   PubMedGoogle Scholar
• Speciale AM, Nicoletti G, Torrisi C et al. Prevalence and antibiotic - resistance of the most important urinary pathogens responsible for non complicated cystitis in women: the IceA2 study. GIMMOC 2005; 9: 3–18.
   Google Scholar
• Rizzo M, Marchetti F, Travaglini F, Trinchieri A, Nickel JC. Prevalence, diagnosis and treatment of prostatitis in Italy: a prospective urology outpatient practice study. BJU International 2003; 92: 955–959.
   PubMed Web of Science ®Google Scholar
• Ferri C, Marchetti F, Nickel JC, Naber KG. Prevalence and clinical management of complicated urinary tract infec-tions in Italy: a prospective multicentre epidemiological study in urological outpatients. J Chemother 2005; 17 (6): 601–606.
   PubMed Web of Science ®Google Scholar
• Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO SENS study. Int J Antimicrob Agents, 2003; 22: S49–S52.
   Web of Science ®Google Scholar
• Naber KG, Bergman B, Bishop MC et al. Guidelines on urinary and male genital tract infection. European Association of Urology, March 2004.
   Google Scholar
• Schito GC, Chezzi C, Nicoletti G et al. Susceptibility of frequent urinary pathogens to fosfomycin trometamol and eight other antibiotics: results of an Italian multicenter survey. Infection, 1992; 20 (suppl 4): S291-S295.
   Google Scholar
• Marchese A, Gualco L, Debbia EA, Schito GC, Schito AM. In vitro activity of fosfomycin against Gram - negative uri-nary pathogens and the biological cost of fosfomycin resis-tance. Int J Antimicrob Agents, 2003; 22: 53–59.
   PubMed Web of Science ®Google Scholar
• Fadda G, Nicoletti G, Schito GC, Tempera G. Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicentre Italian survey: possible impact on guidelines. J Chemother 2005; 17 (3): 251–257.
   PubMed Web of Science ®Google Scholar
• Ti Ty, Kumarasinghe G, Taylor MB et al. What is true community-acquired urinary tract infection? Comparison of pathogens identified in urine from routine outpatient speci-mens and from community clinics in a prospective study. Eur J Clin Microbiol Infect Dis 2003; 22: 242–245.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Method for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically. Approved standard, 5th edition. M100-S10 (M7), NCCLS, Wayne, PA, 2004.
   Google Scholar
• Wilson ML and Gaido L. Laboratory diagnosis of uri-nary tract infections in adult patients. Clin Infect Dis 2004; 38: 1150–8.
   PubMed Web of Science ®Google Scholar
• Official Journal of the European Communities, Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (Text with EEA rel-evance), L34/13, 5 February 2002.
   Google Scholar
• Cornaglia G, Hryniewicz W, Jarlier V, et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect, 2004; 10: 349–383.
   PubMed Web of Science ®Google Scholar
• Sahm DF, Critchley IA, Kelly II, Karlowsky JA et al. Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and elec-tronic surveillance. Antimicrob Agents Chemother 2001; 45: 267–274.
   Google Scholar
• Gesu GP, Marchetti F, Piccoli L, Cavallero A. Levofloxacin and ciprofloxacin in vitro activity on 4003 bacte-rial clinical isolates collected in 24 Italian laboratories. Antimicrob Agents Chemother 2003; 47 (2): 816–819.
   PubMed Web of Science ®Google Scholar
• Richard D, Toop II, Chambers S et al. Antibiotic resis-tance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories. NZ Med J 2002; 115: 12–4.
   Google Scholar
• Oppenheim BA. Surveillance of antibiotic resistance in urinary tract infections-are we misleading prescribers? Comm Dis Pub Health 2002; 5 (3): 181–182.
   PubMedGoogle Scholar
• Galatti L, Sessa A, Mazzaglia G, et al. Antibiotic pre-scribing for acute and recurrent cystitis in primary care: a 4 year descriptive study. J Antimicrob Chemother 2006; 57: 551–556.
   PubMed Web of Science ®Google Scholar
• Monaco M, D'Ambrosio F, Del Grosso M, et al. Antibiotico-resistenza in Italia: risultati del progetto AR-ISS nel periodo 2003-2004. Microb Med, 2005; 20 (3): 167.
   Google Scholar
• Marchetti F. Can the susceptibility results of 512 clini-cal isolates of Escherichia coli obtained from a selected female population be generalized to the whole community? J Chemother 2005; 17 (4): 67.
   Google Scholar
• Abs JJ, Serrano MG, Gomez-Garces JL, Perianes J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 2005; 11: 199–203.
   PubMed Web of Science ®Google Scholar
• Lopardo G, Fridman D, González-Arzac M, et al. Uropathogen resistance: are laboratory-generated data reliable enough? J Chemother 2007; 19 (1): 33–37.
   PubMed Web of Science ®Google Scholar
• Drago L, De Vecchi E, Nicola L, Valli M, Marchetti F, Gismondo MR. Comparative bactericidal activity of fluoro-quinolones against clinical isolates resistant to fluoro-quinolones. J Chemother 2003; 15 (2): 27–32.
   PubMedGoogle Scholar
• Van Bambeke F, Michot J - M, Van Eldere J, Tulkens PM. Quinolones in 2005: an update. Clin Microbiol Infect, 2005; 11: 256–280.
   Google Scholar
• Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med. 2005; 352: 380–91.
   PubMed Web of Science ®Google Scholar